<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="50077">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02454296</url>
  </required_header>
  <id_info>
    <org_study_id>22702</org_study_id>
    <nct_id>NCT02454296</nct_id>
  </id_info>
  <brief_title>Paracervical Block for Pain Associated With Laminaria Insertion</brief_title>
  <official_title>Paracervical Block for Pain Associated With Laminaria Insertion</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Hawaii</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Hawaii</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To assess if paracervical block is effective at reducing discomfort during placement of
      intracervical laminaria for pre-operative cervical preparation.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Pre-operative dilation of the cervix with use of osmotic dilators (e.g. laminaria,
      dilapan-S) is commonly done prior to pregnancy termination to make the procedure safer. This
      study seeks to assess whether paracervical blocks are effective at reducing pain associated
      with placement of laminaria. Secondarily, this study will evaluate if paracervical blocks
      are effective at reducing overall procedural pain and increasing overall patient
      satisfaction for the intracervical laminaria placement procedure.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>May 2015</start_date>
  <completion_date type="Anticipated">December 2015</completion_date>
  <primary_completion_date type="Anticipated">December 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double Blind (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pain after placement of laminaria (100 mm VAS)</measure>
    <time_frame>Measured within 10 seconds after placement of laminaria</time_frame>
    <description>The research assistant will assess the participant's pain on the 100 mm VAS</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Satisfaction with overall pain control and the overall procedure (100 mm VAS)</measure>
    <time_frame>15 minutes post-operatively</time_frame>
    <description>Patients will rate satisfaction on the 100 mm VAS</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain during other steps in the laminaria insertion procedure (100 mm VAS)</measure>
    <time_frame>Pain will be measured at baseline; within 10 seconds after placement of speculum; within 10 seconds of paracervical block or sham block; 15 minutes after end of procedure</time_frame>
    <description>Patients will rate pain on the 100 mm VAS</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Pain</condition>
  <arm_group>
    <arm_group_label>Paracervical Block with lidocaine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>A paracervical block will be done prior to the placement of laminaria with 1% lidocaine and sodium bicarbonate.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sham paracervical block</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>A sham block will be done prior to the placement of laminaria using a capped needle</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Paracervical Block with lidocaine</intervention_name>
    <description>Performance of paracervical block, using 18 mL of 1% lidocaine buffered with 2 mL 8.4% sodium bicarbonate, prior to laminaria insertion</description>
    <arm_group_label>Paracervical Block with lidocaine</arm_group_label>
    <other_name>Paracervical block</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Sham paracervical block</intervention_name>
    <description>A capped needle will be placed on the cervix prior to laminaria insertion for purposes of blinding both the participant and research staff assessing outcomes</description>
    <arm_group_label>Sham paracervical block</arm_group_label>
    <other_name>Sham block; placebo</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Pregnant women between the ages of 18-49 years

          -  Desiring surgical termination of pregnancy or surgical management of a fetal demise

          -  Treatment plan involves cervical preparation with laminaria

          -  Participant able to provide informed consent in English and willing to participate in
             the study

        Exclusion Criteria:

          -  Unable to read/speak/understand English

          -  Contraindications to receiving lidocaine
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>49 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Principal Investigator</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Hawaii</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Principal Investigator</last_name>
    <phone>(808) 203-6500</phone>
    <email>research@fpfellowshiphawaii.org</email>
  </overall_contact>
  <location>
    <facility>
      <name>University Women's Health Specialists</name>
      <address>
        <city>Honolulu</city>
        <state>Hawaii</state>
        <zip>96826</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Principal Investigator</last_name>
      <phone>808-203-6500</phone>
      <email>research@fpfellowshiphawaii.org</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.pdr.net/drug-summary/xylocaine-xylocaine-with-epinephrine-xylocaine-mpf-xylocaine-mfp-with-epinephrine?druglabelid=2543&amp;id=2148</url>
    <description>Summary of lidocaine drug information</description>
  </link>
  <reference>
    <citation>Grimes DA, Schulz KF, Cates WJ Jr. Prevention of uterine perforation during curettage abortion. JAMA. 1984 Apr 27;251(16):2108-11.</citation>
    <PMID>6708260</PMID>
  </reference>
  <reference>
    <citation>Renner RM, Nichols MD, Jensen JT, Li H, Edelman AB. Paracervical block for pain control in first-trimester surgical abortion: a randomized controlled trial. Obstet Gynecol. 2012 May;119(5):1030-7. doi: 10.1097/AOG.0b013e318250b13e.</citation>
    <PMID>22525915</PMID>
  </reference>
  <reference>
    <citation>Kan AS, Ng EH, Ho PC. The role and comparison of two techniques of paracervical block for pain relief during suction evacuation for first-trimester pregnancy termination. Contraception. 2004 Aug;70(2):159-63.</citation>
    <PMID>15288222</PMID>
  </reference>
  <reference>
    <citation>Mercier RJ, Liberty A. Intrauterine lidocaine for pain control during laminaria insertion: a randomized controlled trial. Contraception. 2014 Dec;90(6):594-600. doi: 10.1016/j.contraception.2014.07.008. Epub 2014 Jul 23.</citation>
    <PMID>25139724</PMID>
  </reference>
  <reference>
    <citation>Borgatta L, Roncari D, Sonalkar S, Mark A, Hou MY, Finneseth M, Vragovic O. Mifepristone vs. osmotic dilator insertion for cervical preparation prior to surgical abortion at 14-16 weeks: a randomized trial. Contraception. 2012 Nov;86(5):567-71. doi: 10.1016/j.contraception.2012.05.002. Epub 2012 Jun 6.</citation>
    <PMID>22682721</PMID>
  </reference>
  <reference>
    <citation>Drey EA, Benson LS, Sokoloff A, Steinauer JE, Roy G, Jackson RA. Buccal misoprostol plus laminaria for cervical preparation before dilation and evacuation at 21-23 weeks of gestation: a randomized controlled trial. Contraception. 2014 Apr;89(4):307-13. doi: 10.1016/j.contraception.2013.10.013.</citation>
    <PMID>24560477</PMID>
  </reference>
  <reference>
    <citation>Goldberg AB, Drey EA, Whitaker AK, Kang MS, Meckstroth KR, Darney PD. Misoprostol compared with laminaria before early second-trimester surgical abortion: a randomized trial. Obstet Gynecol. 2005 Aug;106(2):234-41.</citation>
    <PMID>16055570</PMID>
  </reference>
  <reference>
    <citation>Prairie BA, Lauria MR, Kapp N, Mackenzie T, Baker ER, George KE. Mifepristone versus laminaria: a randomized controlled trial of cervical ripening in midtrimester termination. Contraception. 2007 Nov;76(5):383-8. Epub 2007 Oct 4.</citation>
    <PMID>17963864</PMID>
  </reference>
  <reference>
    <citation>Hakim-Elahi E, Tovell HM, Burnhill MS. Complications of first-trimester abortion: a report of 170,000 cases. Obstet Gynecol. 1990 Jul;76(1):129-35.</citation>
    <PMID>2359559</PMID>
  </reference>
  <reference>
    <citation>Blanco LJ, Reid PR, King TM. Plasma lidocaine levels following paracervical infiltration for aspiration abortion. Obstet Gynecol. 1982 Oct;60(4):506-8.</citation>
    <PMID>7121936</PMID>
  </reference>
  <verification_date>November 2015</verification_date>
  <lastchanged_date>November 30, 2015</lastchanged_date>
  <firstreceived_date>May 18, 2015</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Hawaii</investigator_affiliation>
    <investigator_full_name>Reni Soon</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <keyword>Laminaria</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Lidocaine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
